FDA Approves Enhertu and Pertuzumab Combination for First-Line Treatment of Specific Breast Cancers The approval highlights the effectiveness of a new combination therapy in extending progression-free survival. This regulatory decision is based on clinical trial data, demonstrating significant... Obesity Right to health Well-being Dec 16, 2025
Eli Lilly's Orforglipron Demonstrates Superior Efficacy in Type 2 Diabetes and Weight Loss Trials The trials highlight the effectiveness of orforglipron in improving HbA1c levels and facilitating weight loss, outperforming existing treatments. This suggests potential advancements in managing type... Obesity Right to health Well-being Sep 17, 2025